Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) FCF Margin (2019 - 2025)

Biodesix's FCF Margin history spans 7 years, with the latest figure at 2.41% for Q4 2025.

  • For Q4 2025, FCF Margin rose 2656.0% year-over-year to 2.41%; the TTM value through Dec 2025 reached 26.59%, up 4615.0%, while the annual FY2025 figure was 26.59%, 4615.0% up from the prior year.
  • FCF Margin reached 2.41% in Q4 2025 per BDSX's latest filing, up from 41.01% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 6.81% in Q2 2021 to a low of 204.05% in Q1 2022.
  • Average FCF Margin over 5 years is 83.54%, with a median of 81.19% recorded in 2022.
  • Peak YoY movement for FCF Margin: soared 11148bps in 2021, then tumbled -16320bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 148.49% in 2021, then increased by 3bps to 144.46% in 2022, then grew by 28bps to 104.08% in 2023, then soared by 77bps to 24.16% in 2024, then soared by 110bps to 2.41% in 2025.
  • Per Business Quant, the three most recent readings for BDSX's FCF Margin are 2.41% (Q4 2025), 41.01% (Q3 2025), and 33.07% (Q2 2025).